BACKGROUND Sphingolipids (SPs) are ubiquitous, structurally diverse molecules that include ceramides, sphingomyelins (SMs), and sphingosines. They are involved in various pathologies, including obesity and type 2 diabetes mellitus (T2DM). Therefore, it is likely that perturbations in plasma concentrations of SPs are associated with disease. Identifying these associations may reveal useful biomarkers or provide insight into disease processes.METHODS We performed a lipidomics evaluation of molecularly distinct SPs in the plasma of 2302 ethnically Chinese Singaporeans using electrospray ionization mass spectrometry coupled with liquid chromatography. SP profiles were compared to clinical and biochemical characteristics, and subjects were evaluated with follow-up visits for 11 years.RESULTS We found that ceramides correlated positively but hexosylceramides correlated negatively with BMI and homeostatic model assessment of insulin resistance (HOMA-IR). Furthermore, SPs with a d16:1 sphingoid backbone correlated more positively with BMI and HOMA-IR, while d18:2 SPs correlated less positively, relative to canonical d18:1 SPs. We also found that higher concentrations of 2 distinct SMs were associated with a higher risk of T2DM (HR 1.45 with 95% CI 1.18–1.78 for SM d16:1/18:0 and HR 1.40 with 95% CI 1.17–1.68 for SM d18:1/18:0).CONCLUSIONS We identified significant associations between SPs and obesity/T2DM characteristics, specifically, those of hexosylceramides, d16:1 SPs, and d18:2 SPs. This suggests that the balance of SP metabolism, rather than ceramide accumulation, is associated with the pathology of obesity. We further identified 2 specific SPs that may represent prognostic biomarkers for T2DM.FUNDING National University Health System (NUHSRO/2014/085/AF-Partner/01) and the National Research Foundation Investigatorship grant (NRF-NRFI2015-05).
Wee Siong Chew, Federico Torta, Shanshan Ji, Hyungwon Choi, Husna Begum, Xueling Sim, Chin Meng Khoo, Eric Yin Hao Khoo, Wei-Yi Ong, Rob M. Van Dam, Markus R. Wenk, E. Shyong Tai, Deron R. Herr
Title and authors | Publication | Year |
---|---|---|
Plasma Sphingolipid Profile in Association with Incident Metabolic Syndrome in a Chinese Population-Based Cohort Study
H Yun, QB Qi, G Zong, QQ Wu, ZH Niu, SS Chen, HX Li, L Sun, R Zeng, X Lin |
Nutrients | 2021 |
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
AM Fretts, PN Jensen, AN Hoofnagle, B McKnight, BV Howard, J Umans, CM Sitlani, DS Siscovick, IB King, L Djousse, N Sotoodehnia, RN Lemaitre |
Journal of lipid research | 2021 |
Longitudinal Plasma Lipidome and Risk of Type 2 Diabetes in a Large Sample of American Indians With Normal Fasting Glucose: The Strong Heart Family Study
G Miao, Y Zhang, Z Huo, W Zeng, J Zhu, JG Umans, G Wohlgemuth, D Pedrosa, B DeFelice, SA Cole, AM Fretts, ET Lee, BV Howard, O Fiehn, J Zhao |
Diabetes care | 2021 |
Dietary Fat and Protein Intake in Relation to Plasma Sphingolipids as Determined by a Large-Scale Lipidomic Analysis
JY Seah, WS Chew, F Torta, CM Khoo, MR Wenk, DR Herr, ES Tai, RM van Dam |
Metabolites | 2021 |
Association of plasma ceramides with prevalent and incident type 2 diabetes mellitus in middle and older aged adults
SB Dugani, LR Christenson, JA Aakre, HH Bui, A Vella, MM Mielke |
Diabetes Research and Clinical Practice | 2021 |
Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status
K Guo, M Savelieff, A Rumora, F Alakwaa, B Callaghan, J Hur, E Feldman |
The Journal of clinical endocrinology and metabolism | 2021 |
Metabolic View on Human Healthspan: A Lipidome-Wide Association Study
J Carrard, H Gallart-Ayala, D Infanger, T Teav, J Wagner, R Knaier, F Colledge, L Streese, K Königstein, T Hinrichs, H Hanssen, J Ivanisevic, A Schmidt-Trucksäss |
Metabolites | 2021 |
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
A Rohatgi, M Westerterp, A von Eckardstein, A Remaley, KA Rye |
Circulation | 2021 |
Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
M Mah, M Febbraio, S Turpin-Nolan |
Frontiers in Endocrinology | 2021 |
AdipoAtlas: A reference lipidome for human white adipose tissue
M Lange, G Angelidou, Z Ni, A Criscuolo, J Schiller, M Blüher, M Fedorova |
Cell reports. Medicine | 2021 |
Identification of circulating sphingosine kinase-related metabolites for prediction of type 2 diabetes
Q Chen, W Wang, MF Xia, Y Lu, H Bian, C Yu, XY Li, MA Vadas, X Gao, HD Lin, P Xia |
Journal of Translational Medicine | 2021 |
Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study
MR Ferreira, CJ Sands, JV Li, JN Andreyev, E Chekmeneva, S Gulliford, J Marchesi, MR Lewis, DP Dearnaley |
International journal of radiation oncology, biology, physics | 2021 |
Prospective analysis of circulating metabolites and endometrial cancer risk
L Dossus, E Kouloura, C Biessy, V Viallon, AP Siskos, N Dimou, S Rinaldi, MA Merritt, N Allen, R Fortner, R Kaaks, E Weiderpass, IT Gram, JA Rothwell, L Lécuyer, G Severi, MB Schulze, TH Nøst, M Crous-Bou, MJ Sánchez, P Amiano, SM Colorado-Yohar, AB Gurrea, JA Schmidt, D Palli, C Agnoli, R Tumino, C Sacerdote, A Mattiello, R Vermeulen, AK Heath, S Christakoudi, KK Tsilidis, RC Travis, MJ Gunter, HC Keun |
Gynecologic Oncology | 2021 |
Obesity-Related Changes in Human Plasma Lipidome Determined by the Lipidyzer Platform
P Pikó, L Pál, S Szűcs, Z Kósa, J Sándor, R Ádány |
Biomolecules | 2021 |
Revealing the Hypoglycemic Effects and Mechanism of GABA-Rich Germinated Adzuki Beans on T2DM Mice by Untargeted Serum Metabolomics
X Jiang, Q Xu, A Zhang, Y Liu, Z Li, H Tang, D Cao, D Zhang |
Frontiers in Nutrition | 2021 |
Pathways to Severe COVID‐19 for People with Obesity
O\u2019Rourke RW, Lumeng CN |
Obesity (Silver Spring, Md.) | 2021 |